IP Library Patent Application 16583426
Patent Application
App. No. 16/583,426

NASAL ADMINISTRATION

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
16/583,426
Abstract

A delivery device for and method of providing for delivery of substance to the central nervous system (CNS) of a subject, the delivery device comprising: a nosepiece unit ( 17 ) for insertion into a nasal airway ( 1 ) of a subject and comprising an outlet unit ( 21 ) which includes a nozzle ( 25 ) for delivering substance into the nasal airway of the subject; and a substance supply unit which is operable to deliver a dose of substance to the nozzle: wherein the delivery device is configured such that at least 30% of the dose as initially deposited in the nasal airway is deposited in an upper posterior region of the nasal airway, thereby providing a CNS concentration of the substance, and hence CNS effect, which is significantly greater than that which would be predicted from a counterpart blood plasma concentration of the substance.

Claims (8)

1 - 85 . (canceled)

86 . A liquid substance delivery device, comprising:

a housing;

a nosepiece attached to the housing via a snap-fit connection, the nosepiece including an outlet and a cuff member, the cuff member configured to block a nasal valve of a subject when at least a portion of the nosepiece is fitted in a nasal passage of the subject;

a mouthpiece attached to the housing and comprising an inlet, the inlet of the mouthpiece being fluidly connected via the housing to the outlet of the nosepiece;

a liquid delivery pump configured to expel a metered amount of pharmaceutical substance through the outlet of the nosepiece upon actuation of the pump;

a gas supply unit configured to deliver an amount of gas through the outlet of the nosepiece, the delivered gas being a pharmaceutically acceptable gas other than an exhaled air flow;

wherein the liquid delivery pump contains a plurality of metered amounts of the pharmaceutical substance.

Assignments (2)
CHANGE OF ADDRESS Recorded Jan 6, 2025
From: OPTINOSE, INC.
To: OPTINOSE, INC.
Reel/Frame 069825/0281 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 27, 2022
From: OPTINOSE AS
To: OPTINOSE INC
Reel/Frame 061546/0424 →